Erkki Ruoslahti

Erkki Ruoslahti

Auto-generated profile, based on publicly available information

Erkki Ruoslahti

Cancer Research Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA.

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
ERErkki Ruoslahti
Erkki Ruoslahti

22 January 2018 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
SHSazid Hussain
Sazid Hussain
JJJinmyoung Joo
Jinmyoung Joo
JKJinyoung Kang
Jinyoung Kang
BKByungji Kim
Byungji Kim
GBGary B. Braun
Gary B. Braun
ERErkki Ruoslahti
Erkki Ruoslahti


28 June 2016 in Nature Communications
Verified
Journal Article
Open access
AMAman P. Mann
Aman P. Mann
PSPablo Scodeller
Pablo Scodeller
SHSazid Hussain
Sazid Hussain
JJJinmyoung Joo
Jinmyoung Joo
EKEster Kwon
Ester Kwon
ERErkki Ruoslahti
Erkki Ruoslahti
Traumatic brain injury (TBI) is a major health and socio-economic problem, but no pharmacological agent is currently approved for the treatment of acute TBI. Thus, there is a great need for advances in this field. Here, we describe a short peptide (sequence CAQK) identified by in vivo phage display screening in mice with acute brain injury. The CAQK peptide selectively binds to injured mouse and human brain, and systemically injected CAQK specifically homes to sites of brain injury in mouse models. The CAQK target is a proteoglycan complex upregulated in brain injuries. Coupling to CAQK increased injury site accumulation of systemically administered molecules ranging from a drug-sized molecule to nanoparticles. CAQK-coated nanoparticles containing silencing oligonucleotides provided the first evidence of gene silencing in injured brain parenchyma by systemically administered siRNA. These findings present an effective targeting strategy for the delivery of therapeutics in clinical management of acute brain injuries.

17 February 2017 in Nano Letters
Verified
Journal Article
Closed access
SSShweta Sharma
Shweta Sharma
VKVenkata Ramana Kotamraju
Venkata Ramana Kotamraju
TMTarmo Mölder
Tarmo Mölder
ATAllan Tobi
Allan Tobi
TTTambet Teesalu
Tambet Teesalu
ERErkki Ruoslahti
Erkki Ruoslahti

6 November 2015 in Science Advances
Verified
Journal Article
Open access
PDF file
HPHong-Bo Pang
Hong-Bo Pang
GBGary B. Braun
Gary B. Braun
ERErkki Ruoslahti
Erkki Ruoslahti
Two cell entry mechanisms cooperate in peptide-mediated intracellular delivery.